Inventor profile of:

Barry D. Quart

City:

Encinitas, California

Country:

United States

Published Applications:

28

Last publication date:

2020-03-12

Top Assignees for applications by Barry D. Quart

The entities that hold a legal rights for patent applications filed by inventor Quart Barry D.:

Recent patent applications by Quart Barry D.

Barry D. Quart from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-03-12
US20200078363A1
Human necessities

POST-SURGICAL PAIN TREATMENT

#2 | 2019-05-16
US20190142805A1
Human necessities

Novel Compounds and Compositions and Methods of Use

#3 | 2019-05-09
US20190135756A1
Chemistry; metallurgy

3,4-di-substituted pyridine compound, methods of using and compositions comprising the same

#4 | 2019-01-17
US20190015392A1
Human necessities

Treatment of Gout and Hyperuricemia

#5 | 2018-06-14
US20180161314A1
Human necessities

Methods for Treating Hyperuricemia and Related Diseases

#6 | 2017-10-05
US20170281601A1
Human necessities

Compounds and compositions and methods of use

#7 | 2016-12-29
US20160374993A1
Human necessities

TREATMENT OF GOUT

#8 | 2016-08-04
US20160221970A1
Chemistry; metallurgy

NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

#9 | 2016-05-26
US20160143889A1
Human necessities

TREATMENT OF GOUT AND HYPERURICEMIA

#10 | 2015-03-05
US20150065566A1
Human necessities

Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer

#11 | 2014-09-11
US20140256748A1
Chemistry; metallurgy

3,4-di-substituted pyridine compound, methods of using and compositions comprising the same

#12 | 2014-01-02
US20140005136A1
Chemistry; metallurgy

NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

#13 | 2013-11-07
US20130296345A1
Human necessities

METHODS FOR TREATING HYPERURICEMIA AND RELATED DISEASES

#14 | 2013-07-11
US20130178484A1
Human necessities

Treatment of gout and hyperuricemia

#15 | 2013-03-07
US20130059868A1
Human necessities

Treatment of gout

#16 | 2012-07-26
US20120189720A1
Human necessities

Method for treatment of diarrhea-predominant irritable bowel syndrome

#17 | 2012-06-28
US20120164222A1
Human necessities

Compounds and compositions and methods of use

#18 | 2012-05-24
US20120128797A1
Human necessities

Method for treatment of constipation-predominant irritable bowel syndrome

#19 | 2011-12-01
US20110293719A1
Human necessities

Compounds and compositions and methods of use

#20 | 2011-11-03
US20110268801A1
Human necessities

Compounds and compositions and methods of use

#21 | 2011-10-06
US20110244049A1
Human necessities

COMPOSITIONS COMPRISING 4-(2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETAMIDO)-3-CHLOROBENZOIC ACID AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND METHODS FOR PREPARING AND USING SAME

#22 | 2011-02-10
US20110033539A1
Human necessities

Compositions and methods for preparing and using same

#23 | 2009-09-24
US20090238901A1
Human necessities

Method for treatment of constipation-predominant irritable bowel syndrome

#24 | 2009-08-06
US20090197825A1
Human necessities

Compounds and compositions and methods of use

#25 | 2008-10-09
US20080249066A1
Human necessities

ANTIVIRAL COMPOUNDS AND COMPOSITIONS

#26 | 2008-02-07
US20080031984A1
Human necessities

Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer

#27 | 2008-02-07
US20080031983A1
Human necessities

Method for treatment of constipation-predominant irritable bowel syndrome

#28 | 2007-11-01
US20070254050A1
Human necessities

Method for treatment of diarrhea-predominant irritable bowel syndrome

InventorID:

129065 ⎘